![Konrad Reinhart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konrad Reinhart
Director/Miembro de la Junta en Friedrich Schiller University of Jena .
Perfil
Konrad Reinhart is Founder of SIRS-Lab GmbH.
He is Director of the Clinic for Anaesthesiology and Intensive Therapy at the University of Jena, President of the German Sepsis Society and a Director of the International Sepsis Forum.
Dr. Reinhart was appointed as Council Member of the World Federation Societies of Intensive and Critical Care Medicine in 2005.
He was Secretary of the European Society of Intensive Care Medicine.
Cargos activos de Konrad Reinhart
Empresas | Cargo | Inicio |
---|---|---|
Friedrich Schiller University of Jena | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Konrad Reinhart.
Empresas | Cargo | Fin |
---|---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Konrad Reinhart